Rappel de Device Recall Baxter PCA II Syringe Infusion Pump

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Baxter Healthcare Corp..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    34244
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
    Z-0553-06
  • Date de mise en oeuvre de l'événement
    2005-12-21
  • Date de publication de l'événement
    2006-04-26
  • Statut de l'événement
    Terminated
  • Pays de l'événement
  • Date de fin de l'événement
    2008-11-03
  • Source de l'événement
    USFDA
  • URL de la source de l'événement
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notes supplémentaires dans les données
    Pump, Infusion, Pca - Product Code MEA
  • Cause
    Delivery of unrequested pca doses of medication due to damaged pca cords, partial sticking of pca button, and fluid ingress into the pump or pca button.
  • Action
    Baxter sent Urgent Device Correction letters dated 12/21/05 to the direct accounts on the same date via first class mail. The letters informed the accounts of the potential for unrequested PCA doses due to an electrical short in the PCA circuit simulating repeated pressing of the PCA button. The unrequested bolus doses will not exceed the programmed prescription limits. The letter listed three conditions identified that can produce an electrical short in the PCA circuit and simulate repeated pressing of the PCA button: * Damaged PCA cord or button, * Partial sticking of the PCA button, and * Fluid ingress into the pump or PCA button. Information was provided to reduce the potential for these conditions from occurring during use of the pumps. Customers were asked to ensure that prior to or after each use the PCA cord is intact and has no cuts or missing insulation, and that the pump connector and the button are securely attached to the cord. They were also asked to immediately take the pump and PCA cord out of service for repair if the pump displays 'Release the PCA Button' and the PCA button is not being intentionally pressed, as there may be a mechanical or electronic fault in the PCA button. They were also asked two avoid getting liquids inside the pump as permanent damage may result. Baxter recommended that the institutions implement a regular preventative maintenance program and periodic replacement of the PCA cords based on their own specific usage patterns. Any questions were directed to the Center for One Baxter at 1-800-422-9837. Baxter sent a follow-up recall letter to the accounts on 6/21/06, providing them with an Operator's Manual Addendum for the AP II Infusion Pump and the PCA II Infusion Pump, with the warnings to ensure that prior to or after each use that the PCA cord is intact and has no cuts or missing insulation, and that the pump connector and the button are securely attached to the cord; to avoid getting liquids inside the pump; and

Device

  • Modèle / numéro de série
    all serial numbers
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Nationwide including Puerto Rico, and internationally to Canada, Chile, China, Hong Kong, Korea, Kuwait, Malaysia, Taiwan and Saudi Arabia
  • Description du dispositif
    Baxter PCA II Syringe Infusion Pump, product codes 2L3104 and 2L3104R; Baxter Healthcare Corporation, Deerfield, IL 60015
  • Manufacturer

Manufacturer

  • Adresse du fabricant
    Baxter Healthcare Corp., Rt. 120 & Wilson Rd, Round Lake IL 60073
  • Source
    USFDA